{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:55:47Z","timestamp":1783047347931,"version":"3.54.6"},"reference-count":54,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":322,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Eur J of Neuroscience"],"published-print":{"date-parts":[[2001,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Parkinson's disease (PD) is associated with a progressive loss of dopamine neurons in the substantia nigra and degeneration of dopaminergic terminals in the striatum. Although <jats:sc>l<\/jats:sc>\u2010DOPA treatment provides the most effective symptomatic relief for PD it does not prevent the progression of the disease, and its long\u2010term use is associated with the onset of dyskinesia. In rodent and primate studies, glial cell line\u2010derived neurotrophic factor (GDNF) may prevent 6\u2010OHDA\u2010 or MPTP\u2010induced nigral degeneration and so may be beneficial in the treatment of PD. In this study, we investigate the effects of GDNF on the expression of dyskinesia in <jats:sc>l<\/jats:sc>\u2010DOPA\u2010primed MPTP\u2010treated common marmosets, exhibiting dyskinesia. GDNF or saline was administered by two intraventricular injections, 4\u2003weeks apart, to MPTP\u2010treated, <jats:sc>l<\/jats:sc>\u2010DOPA\u2010treated common marmosets primed to exhibit dyskinesia. Prior to GDNF or saline administration, all animals displayed marked dyskinesia when treated with <jats:sc>l<\/jats:sc>\u2010DOPA. GDNF administration produced a significant improvement in motor disability and, following the second injection of GDNF, a significant improvement in the locomotor activity was observed. Following the administration of <jats:sc>l<\/jats:sc>\u2010DOPA there was a greater reversal of disability and a reduction in the intensity of <jats:sc>l<\/jats:sc>\u2010DOPA\u2010induced dyskinesia in GDNF\u2010treated animals compared to saline\u2010treated controls. However, there was no significant difference in <jats:sc>l<\/jats:sc>\u2010DOPA's ability to increase locomotor activity between GDNF\u2010treated and saline\u2010treated animals. GDNF treatment caused a significant increase in the number of tyrosine hydroxylase\u2010positive neurons in the substantia nigra, but no change in [<jats:sup>3<\/jats:sup>H]mazindol binding to dopamine terminals was found in the striatum of GDNF\u2010treated animals compared to saline\u2010treated controls. In GDNF\u2010treated animals a small but significant reduction in enkephalin mRNA was observed in the caudate nucleus but not in the putamen or the nucleus accumbens. Substance P mRNA expression was equally reduced in the caudate nucleus and the putamen of the GDNF\u2010treated animals but not in the nucleus accumbens. Intraventricular administration of GDNF improved MPTP\u2010induced disability and reversed dopamine cell loss in the substantia nigra. GDNF also diminished <jats:sc>l<\/jats:sc>\u2010DOPA\u2010induced dyskinesia, which may relate to its ability to partly restore nigral dopaminergic transmission or to modify the activity of striatal output pathways.<\/jats:p>","DOI":"10.1046\/j.1460-9568.2001.01408.x","type":"journal-article","created":{"date-parts":[[2003,3,6]],"date-time":"2003-03-06T14:37:20Z","timestamp":1046961440000},"page":"597-608","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["GDNF reverses priming for dyskinesia in MPTP\u2010treated, <scp>l<\/scp>\u2010DOPA\u2010primed common marmosets"],"prefix":"10.1111","volume":"13","author":[{"given":"Mahmoud M.","family":"Iravani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu C.","family":"Tel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Cannizzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald K. B.","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Jenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-70140-5_19"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0169-328X(89)90032-6"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00229549"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)90802-4"},{"key":"e_1_2_6_6_1","first-page":"S70","article-title":"Molecular basis of levodopa\u2010induced dyskinesias","volume":"47","author":"Calon F.","year":"2000","journal-title":"Ann. Neurol."},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.1998.00285.x"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.275.5301.838"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004410050867"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(00)00933-X"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/syn.890180303"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/114.5.2283"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/cne.903630302"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/380252a0"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2006.113050"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.11-04-01016.1991"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-8993(98)01244-x"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(95)00086-z"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/syn.890140212"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-8993(96)00345-9"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(94)90218-6"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004410050694"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.7.2173"},{"key":"e_1_2_6_24_1","first-page":"S90","article-title":"Factors influencing the onset and persistence of dyskinesia in MPTP\u2010treated primates","volume":"47","author":"Jenner P.","year":"2000","journal-title":"Ann. Neurol."},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(84)90467-1"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0169-328x(95)00084-6"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(94)01366-p"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.17-18-07111.1997"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-8993(97)01495-9"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-8993(96)01265-6"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0306-4522(97)83045-x"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1006\/neur.1996.0027"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)91146-1"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-2999(96)00756-x"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410240415"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410420212"},{"key":"e_1_2_6_37_1","first-page":"24","article-title":"A review of some aspects of the pharmacology of levodopa","volume":"15","author":"Morris J.G.","year":"1978","journal-title":"Clin. Exp. Neurol."},{"key":"e_1_2_6_38_1","first-page":"11","article-title":"Motor complications associated with chronic levodopa therapy in Parkinson's disease","volume":"39","author":"Obeso J.A.","year":"1989","journal-title":"Neurology"},{"key":"e_1_2_6_39_1","first-page":"S167","article-title":"Preventing levodopa\u2010induced dyskinesias","volume":"47","author":"Olanow C.W.","year":"2000","journal-title":"Ann. Neurol."},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1098-2396(199607)23:3<192::aid-syn8>3.3.co;2-6"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870100606"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.18-11-04106.1998"},{"key":"e_1_2_6_43_1","first-page":"S179","article-title":"Medical treatment of levodopa\u2010induced dyskinesias","volume":"47","author":"Rascol O.","year":"2000","journal-title":"Ann. Neurol."},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.1999.00566.x"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.19.8935"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199804200-00025"},{"key":"e_1_2_6_47_1","volume-title":"The Brain of Common Marmoset: a Stereotaxic Atlas","author":"Stephan B.","year":"1980"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.1998.00016.x"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/373335a0"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.18.8274"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.17-01-00325.1997"},{"key":"e_1_2_6_52_1","first-page":"1140","article-title":"Glial cell line\u2010derived neurotrophic factor sustains axotomized basal forebrain cholinergic neurons in vivo: dose\u2013response comparison to nerve growth factor and brain\u2010derived neurotrophic factor","volume":"277","author":"Williams L.R.","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.16-22-07206.1996"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(94)00574-o"},{"key":"e_1_2_6_55_1","first-page":"1396","article-title":"Dose response to intraventricular glial cell line\u2010derived neurotrophic factor administration in parkinsonian monkeys","volume":"282","author":"Zhang Z.","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["European Journal of Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1460-9568.2001.01408.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1460-9568.2001.01408.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T17:50:18Z","timestamp":1696614618000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1460-9568.2001.01408.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,2]]}},"alternative-id":["10.1046\/j.1460-9568.2001.01408.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1460-9568.2001.01408.x","archive":["Portico"],"relation":{},"ISSN":["0953-816X","1460-9568"],"issn-type":[{"value":"0953-816X","type":"print"},{"value":"1460-9568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,2]]},"assertion":[{"value":"2001-12-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}